Data indicate that HMGB1, HMGB2, as well as most of their targets identified in our Y2H study are expressed at higher levels in ovarian adenocarcinoma than in normal ovarian tissue, following a pattern of co-regulation that is frequently found among genes encoding proteins that interact with each other [101]. This evidence concerns the gene HMGB1 and ovarian adenocarcinoma.